TVM Capital Life Science is a leading international venture capital firm focused on investing in life science innovations, including therapeutics and medical technologies. With approximately $900 million under management, the firm leverages its extensive experience and network to identify and nurture high-impact innovations across the transatlantic investments.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions